{
    "pmcid": "10590698",
    "qa_pairs": {
        "How were the nanobodies engineered to enhance their stability and half-life?": [
            "By including the Fc domain of human IgG",
            "By adding a polyethylene glycol (PEG) moiety",
            "By fusing with albumin",
            "By incorporating a lipid tail"
        ],
        "What is the primary target for neutralizing antibodies in SARS-CoV-2, as discussed in the study?": [
            "The spike protein",
            "The nucleocapsid protein",
            "The membrane protein",
            "The envelope protein"
        ],
        "What potential delivery method is proposed for optimizing the distribution of nanobodies in the lungs?": [
            "Aerosolized delivery",
            "Oral administration",
            "Intravenous injection",
            "Subcutaneous injection"
        ],
        "What specific domain of the SARS-CoV-2 spike protein do the nanobodies target?": [
            "The receptor-binding domain (RBD)",
            "The N-terminal domain (NTD)",
            "The S2 subunit",
            "The fusion peptide"
        ],
        "Which nanobody was identified as having the most comprehensive neutralization coverage against SARS-CoV-2 variants?": [
            "aVHH-13-Fc",
            "aVHH-11-Fc",
            "aVHH-14-Fc",
            "aVHH-12-Fc"
        ]
    }
}